Levocetirizin Stada

Levocetirizine, the active ingredient in Levocetirizin Stada, is a H1 receptor antagonist presented as an oral tablet for oral use. It is indicated for the relief of symptoms associated with allergic rhinitis and chronic urticaria in adults and children when appropriate. GNH USA supplies Levocetirizin Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levocetirizin Stada is an antihistamine that acts on the H1‑mediated allergic pathway. - Allergic rhinitis: reduces sneezing, nasal itching, and rhinorrhea. - Seasonal allergic rhinitis: alleviates symptoms triggered by pollen or other seasonal allergens. - Chronic urticaria: diminishes the frequency and severity of hives and associated itching.

Levocetirizin Stada is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Drowsiness: mild to moderate sleepiness, especially after the first dose. - Fatigue: a feeling of reduced energy or tiredness. - Dry mouth: decreased salivation leading to a dry oral cavity. - Headache: mild to moderate head discomfort. - Nausea: occasional stomach upset or queasiness. - Altered taste: transient metallic or bitter sensation.

Serious or Rare Side Effects: - Angioedema: swelling of face, lips, tongue, or throat requiring urgent care. - Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Anaphylaxis: rapid onset of systemic allergic response. - Thrombocytopenia: unusually low platelet count. - Hepatic dysfunction: abnormal liver enzyme elevations. - Cardiac arrhythmia: rare irregular heart rhythm events.

Before initiating therapy, clinicians should consider several safety aspects. - Renal function assessment: dose adjustment may be needed in impaired clearance. - Monitor drowsiness: advise patients about potential sedation, especially when driving. - Avoid alcohol: concurrent intake can intensify central nervous system depression. - Pregnancy caution: use only if the potential benefit outweighs risk, after professional evaluation. - Review concomitant CNS depressants: assess additive sedative effects. - Store at ambient temperature: keep in the original pack, protect from moisture.

Levocetirizin Stada may interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole): may raise levocetirizine plasma levels. - Other H1 antihistamines: concurrent use can increase anticholinergic burden.

Moderate Interactions (Monitor Closely): - Alcohol and sedative agents: can enhance drowsiness. - Theophylline: may modestly increase the risk of central nervous system effects. - Warfarin: occasional reports of altered INR; monitor coagulation parameters if combined.